Literature DB >> 33679745

Utilizing Computational Machine Learning Tools to Understand Immunogenic Breadth in the Context of a CD8 T-Cell Mediated HIV Response.

Ed McGowan1, Rachel Rosenthal2, Andrew Fiore-Gartland3, Gladys Macharia1, Sheila Balinda4, Anne Kapaata4, Gisele Umviligihozo5, Erick Muok5, Jama Dalel1, Claire L Streatfield1, Helen Coutinho1, Dario Dilernia6, Daniela C Monaco6, David Morrison7, Ling Yue6, Eric Hunter6, Morten Nielsen8, Jill Gilmour1, Jonathan Hare9.   

Abstract

Predictive models are becoming more and more commonplace as tools for candidate antigen discovery to meet the challenges of enabling epitope mapping of cohorts with diverse HLA properties. Here we build on the concept of using two key parameters, diversity metric of the HLA profile of individuals within a population and consideration of sequence diversity in the context of an individual's CD8 T-cell immune repertoire to assess the HIV proteome for defined regions of immunogenicity. Using this approach, analysis of HLA adaptation and functional immunogenicity data enabled the identification of regions within the proteome that offer significant conservation, HLA recognition within a population, low prevalence of HLA adaptation and demonstrated immunogenicity. We believe this unique and novel approach to vaccine design as a supplement to vitro functional assays, offers a bespoke pipeline for expedited and rational CD8 T-cell vaccine design for HIV and potentially other pathogens with the potential for both global and local coverage.
Copyright © 2021 McGowan, Rosenthal, Fiore-Gartland, Macharia, Balinda, Kapaata, Umviligihozo, Muok, Dalel, Streatfield, Coutinho, Dilernia, Monaco, Morrison, Yue, Hunter, Nielsen, Gilmour and Hare.

Entities:  

Keywords:  CD8 T-cells; HIV; T-cell epitopes; machine learning; vaccines

Mesh:

Substances:

Year:  2021        PMID: 33679745      PMCID: PMC7930081          DOI: 10.3389/fimmu.2021.609884

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  36 in total

1.  First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector.

Authors:  Lindsey R Baden; Stephen R Walsh; Michael S Seaman; Yehuda Z Cohen; Jennifer A Johnson; J Humberto Licona; Rachel D Filter; Jane A Kleinjan; Jon A Gothing; Julia Jennings; Lauren Peter; Joseph Nkolola; Peter Abbink; Erica N Borducchi; Marinela Kirilova; Kathryn E Stephenson; Poonam Pegu; Michael A Eller; Hung V Trinh; Mangala Rao; Julie A Ake; Michal Sarnecki; Steven Nijs; Katleen Callewaert; Hanneke Schuitemaker; Jenny Hendriks; Maria G Pau; Frank Tomaka; Bette T Korber; Galit Alter; Raphael Dolin; Patricia L Earl; Bernard Moss; Nelson L Michael; Merlin L Robb; Dan H Barouch
Journal:  J Infect Dis       Date:  2018-07-13       Impact factor: 5.226

2.  HIV populations are large and accumulate high genetic diversity in a nonlinear fashion.

Authors:  Frank Maldarelli; Mary Kearney; Sarah Palmer; Robert Stephens; JoAnn Mican; Michael A Polis; Richard T Davey; Joseph Kovacs; Wei Shao; Diane Rock-Kress; Julia A Metcalf; Catherine Rehm; Sarah E Greer; Daniel L Lucey; Kristen Danley; Harvey Alter; John W Mellors; John M Coffin
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

3.  Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm.

Authors:  Melissa D Simek; Wasima Rida; Frances H Priddy; Pham Pung; Emily Carrow; Dagna S Laufer; Jennifer K Lehrman; Mark Boaz; Tony Tarragona-Fiol; George Miiro; Josephine Birungi; Anton Pozniak; Dale A McPhee; Olivier Manigart; Etienne Karita; André Inwoley; Walter Jaoko; Jack Dehovitz; Linda-Gail Bekker; Punnee Pitisuttithum; Robert Paris; Laura M Walker; Pascal Poignard; Terri Wrin; Patricia E Fast; Dennis R Burton; Wayne C Koff
Journal:  J Virol       Date:  2009-05-13       Impact factor: 5.103

4.  Quantitative effect of suboptimal codon usage on translational efficiency of mRNA encoding HIV-1 gag in intact T cells.

Authors:  Kholiswa C Ngumbela; Kieran P Ryan; Rohini Sivamurthy; Mark A Brockman; Rajesh T Gandhi; Nina Bhardwaj; Daniel G Kavanagh
Journal:  PLoS One       Date:  2008-06-04       Impact factor: 3.240

5.  Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa.

Authors:  Pauli N Amornkul; Etienne Karita; Anatoli Kamali; Wasima N Rida; Eduard J Sanders; Shabir Lakhi; Matt A Price; William Kilembe; Emmanuel Cormier; Omu Anzala; Mary H Latka; Linda-Gail Bekker; Susan A Allen; Jill Gilmour; Patricia E Fast
Journal:  AIDS       Date:  2013-11-13       Impact factor: 4.177

6.  An integrated map of HIV genome-wide variation from a population perspective.

Authors:  Guangdi Li; Supinya Piampongsant; Nuno Rodrigues Faria; Arnout Voet; Andrea-Clemencia Pineda-Peña; Ricardo Khouri; Philippe Lemey; Anne-Mieke Vandamme; Kristof Theys
Journal:  Retrovirology       Date:  2015-02-15       Impact factor: 4.602

7.  Pooled-Peptide Epitope Mapping Strategies Are Efficient and Highly Sensitive: An Evaluation of Methods for Identifying Human T Cell Epitope Specificities in Large-Scale HIV Vaccine Efficacy Trials.

Authors:  Andrew Fiore-Gartland; Bryce A Manso; David P Friedrich; Erin E Gabriel; Greg Finak; Zoe Moodie; Tomer Hertz; Stephen C De Rosa; Nicole Frahm; Peter B Gilbert; M Juliana McElrath
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

8.  NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data.

Authors:  Birkir Reynisson; Bruno Alvarez; Sinu Paul; Bjoern Peters; Morten Nielsen
Journal:  Nucleic Acids Res       Date:  2020-07-02       Impact factor: 16.971

9.  HIV transmission. Selection bias at the heterosexual HIV-1 transmission bottleneck.

Authors:  Jonathan M Carlson; Malinda Schaefer; Daniela C Monaco; Rebecca Batorsky; Daniel T Claiborne; Jessica Prince; Martin J Deymier; Zachary S Ende; Nichole R Klatt; Charles E DeZiel; Tien-Ho Lin; Jian Peng; Aaron M Seese; Roger Shapiro; John Frater; Thumbi Ndung'u; Jianming Tang; Paul Goepfert; Jill Gilmour; Matt A Price; William Kilembe; David Heckerman; Philip J R Goulder; Todd M Allen; Susan Allen; Eric Hunter
Journal:  Science       Date:  2014-07-10       Impact factor: 47.728

View more
  1 in total

1.  Artificial Intelligence in Vaccine and Drug Design.

Authors:  Sunil Thomas; Ann Abraham; Jeremy Baldwin; Sakshi Piplani; Nikolai Petrovsky
Journal:  Methods Mol Biol       Date:  2022
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.